JDRF Official Statement on Bigfoot Unity Diabetes Management FDA Clearance
May 11, 2021
May 11, 2021
NEW YORK, May 11 -- JDRF, a non-profit dedicated to funding type 1 diabetes research, issued the following agency statement:
* * *
JDRF applauds the U.S. Food and Drug Administration (FDA) on its decision to provide clearance for the Bigfoot Unity(TM) Diabetes Management by Bigfoot Biomedical.
This new system fills a critical gap and brings benefits of automation and device interconnectedness to people with diabetes who rely on multiple daily injections to . . .
* * *
JDRF applauds the U.S. Food and Drug Administration (FDA) on its decision to provide clearance for the Bigfoot Unity(TM) Diabetes Management by Bigfoot Biomedical.
This new system fills a critical gap and brings benefits of automation and device interconnectedness to people with diabetes who rely on multiple daily injections to . . .